Meeting of the immunization  Strategic Advisory Group of Experts,  April 2009--conclusions and  recommendations.
D000349:Africa / Q000453:epidemiology; D001210:Asia, Southeastern / Q000453:epidemiology; D002648:Child; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D017589:Immunization Programs / Q000592:standards; D053124:Influenza A Virus, H5N1 Subtype; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000627:therapeutic use; D008877:Middle East / Q000453:epidemiology; D011051:Poliomyelitis / Q000517:prevention & control; D023321:Poliovirus Vaccines / Q000627:therapeutic use; D012400:Rotavirus Infections / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000627:therapeutic use; D014944:World Health Organization / Q000458:organization & administration
D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D008458:Measles Vaccine; D023321:Poliovirus Vaccines; D022243:Rotavirus Vaccines